Demyelinating Diseases  >>  glutathione PEGylated liposomal methylprednisolone (ENX-201)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
glutathione PEGylated liposomal methylprednisolone (ENX-201) / 2-BBB, TTY Biopharm
NCT02048358: Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients

Terminated
1
47
Europe
2B3-201, 2B3-201: glutathione PEGylated-liposomal methylprednisolone, Placebo, 5% Dextrose, Methylprednisolone hemisuccinate, Solu-Medrol
BBB-Therapeutics B.V.
Healthy Volunteers, Multiple Sclerosis
01/15
02/15
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
glutathione PEGylated liposomal methylprednisolone (ENX-201) / 2-BBB, TTY Biopharm
NCT02048358: Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients

Terminated
1
47
Europe
2B3-201, 2B3-201: glutathione PEGylated-liposomal methylprednisolone, Placebo, 5% Dextrose, Methylprednisolone hemisuccinate, Solu-Medrol
BBB-Therapeutics B.V.
Healthy Volunteers, Multiple Sclerosis
01/15
02/15

Download Options